MedCity News
SEPTEMBER 19, 2022
Much like a house of mirrors, responsibility for understanding and mitigating cyber risk in healthcare is difficult to distinguish and often depends on who you ask, especially when it comes to non-enterprise systems and devices.
Pharmaceutical Technology
SEPTEMBER 19, 2022
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorisation for AstraZeneca ’s Evusheld (formerly AZD7442) for Covid-19 in the European Union (EU). This therapy is intended to treat adult and adolescent Covid-19 patients aged 12 years and above, who do not need additional oxygen and are at greater disease progression risk.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
SEPTEMBER 19, 2022
Experts think virtual reality (VR) can help address the country’s rising levels of pain and anxiety. By flooding the brain with positive signals, VR experiences can act as a drug-free alternative to pain and mental health management — and hospitals across the nation are deploying the technology.
Pharmaceutical Technology
SEPTEMBER 19, 2022
The US Food and Drug Administration (FDA) has awarded Accelerated Approval for bluebird bio ’s Skysona (elivaldogene autotemcel; eli-cel) for slowing neurologic dysfunction progression in early, active cerebral adrenoleukodystrophy (CALD) patients. The treatment is indicated for usage in boys aged four to 17 years with CALD. Through certain Qualified Treatment Centers in the country, Skysona is anticipated to be made available commercially by the end of this year.
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
MedCity News
SEPTEMBER 19, 2022
Many startups are giving patients options to receive care that cuts out insurers. This includes online pharmacies, direct primary care platforms and lending companies. These startups are creating change among payers, some experts say.
Pharma Pathway
SEPTEMBER 19, 2022
Lupin Limited – Walk-In Interview for Quality Control On 20th September 2022. Job Description. Department: Quality Control. Designation: Officer/ Executive. Experience : 02- 07 years. Job Location: Visakhapatnam. Desired Candidate profile: Analysis of Raw Materials, Inprocess, Intermediate finished products & Stability analysis by HPLC, GC, PSD, pXRD, IR, UV, & KF instruments.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Medgadget
SEPTEMBER 19, 2022
Researchers at the City University of Hong Kong have developed a magnetic soft millirobot that can grab and release objects, and move around by rolling. The device can be controlled using magnetic fields, and consists of a biodegradable gelatin and iron oxide microparticles. The technology has significant potential as a minimally invasive drug delivery system, perhaps in the gastrointestinal tract, and may even lead to soft robots that can carry out surgical procedures within the body.
MedCity News
SEPTEMBER 19, 2022
Liver disease remains the focus of Genfit, despite a high-profile clinical trial failure in the fatty liver disease NASH. The company is building out its pipeline by acquiring Versantis, a clinical-stage biotech whose most advanced drug candidate brings a novel approach to treating a deadly chronic liver disease complication that has no FDA-approved therapies.
Pharma Pathway
SEPTEMBER 19, 2022
Sai Life Sciences Limited- Walk-In Interview for Production- Chemists On 25th Sept’ 2022. Job Description. Sai Life Sciences delivers advanced Discovery, Contract Development and Manufacturing Solutions, through a broad suite of expert capabilities across the molecular lifecycle. Interested and eligible candidates can attend interview on scheduled Time & Venue.
MedCity News
SEPTEMBER 19, 2022
Hospitals struggle to retain switchboard and call center staff, a situation exacerbated by inflation. Here’s how Parlance is leveraging its call automation tech to help address these needs and improve the caller experience.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
MedReps
SEPTEMBER 19, 2022
There’s no shortage of challenges for those new to pharma, medical sales and even veterans. Often we’re lucky if we even get to see our physicians, let alone overcome their objections regarding insurance coverage and competitive claims. Then, there are internal hurdles like compliance standards and ever-increasing goals. As a result, a job known for its high compensation and prestige can appear much more gritty and taxing.
MedCity News
SEPTEMBER 19, 2022
More flexibility and control over shift scheduling, tools to reduce admin burnout, and same-day pay all go a long way in helping to relieve the looming burnout crisis.
Toolyt
SEPTEMBER 19, 2022
According to the study conducted by Gartner in 2022, only 14% of organizations have achieved a customer 360* view. When everyone is pushing hard to get more data on customers, often it paves way for incorrect, bad, and risky data, ultimately leading to negative customer support. In the current market trends, understanding what customers want from you paves the way to long-term success.
MedCity News
SEPTEMBER 19, 2022
Among the topics of discussion at the event within the HLTH conference are: making the future of food and nutrition accessible and sustainable, managing and monitoring sleep health, and destigmatizing sexual health and wellness. Register today!
Advertiser: ZoomInfo
In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.
pharmaphorum
SEPTEMBER 19, 2022
French pharma company Genfit has reached a deal to buy Versantis of Switzerland, adding three development-stage drug candidates to its portfolio of experimental liver disease therapies and continuing a strategy change first unveiled in 2020. That change was forced by disappointing clinical trial results with Genfit’s lead drug elafibranor in non-alcoholic steatohepatitis (NASH), and included a pledge to build a pipeline in rare liver diseases behind elafibranor – now redirected at primary
MedCity News
SEPTEMBER 19, 2022
To more effectively implement meaningful solutions that help ensure that access to affordable sexual and reproductive healthcare is treated as a right and not a privilege, we must identify and examine why these challenges persist.
Medico Reach
SEPTEMBER 19, 2022
The effective adoption of telehealth gained momentum after the pandemic phase. Today, healthcare companies and experts are capitalizing on this technology to refine their services. Almost 44% of physicians forecast telehealth use to attend to half of their appointments. Hence, telemedicine is here to stay and grow exponentially, be it in local retail clinics or large-scale healthcare organizations.
MedCity News
SEPTEMBER 19, 2022
It is the first LVAD trial to examine five-year outcomes and surpasses a previous Abbott study on HeartMate 3, which recorded a survival time of two years. The device was found to reduce morbidity and mortality, largely because of fewer deaths by stroke, clotting and bleeding.
Advertiser: ZoomInfo
Shifting to an account-based marketing (ABM) strategy can be both exciting and challenging. Well-implemented ABM motions build engagement with high-value accounts and drive impactful campaigns that resonate with your audience. But where do you begin, and how do you progress from crawling to running? Watch now as Demand Gen experts delve into the essentials of each stage of the ABM process.
CLD, Inc.
SEPTEMBER 19, 2022
As a training manager, you can make short Monday training assignments work for you. After new hire training, sales representatives often complain that it was all “too much too fast.” Representatives absorb as much as possible, but most would benefit from additional training that refreshes their memory of key topics and helps them apply their knowledge and skills.
MedCity News
SEPTEMBER 19, 2022
Transcarent is the latest to join a long list of companies hoping to transform the world of pharmacy benefits and prescription drugs. But its CEO declares Transcarent is marrying healthcare delivery with easy, affordable access to pharmaceuticals and creating a more unified experience for employees.
Pharmaceutical Technology
SEPTEMBER 19, 2022
The European Commission (EC) has granted approval for Bristol Myers Squibb ’s (BMS) fixed-dose combination, Opdualag (nivolumab and relatlimab), as first-line therapy to treat advanced (unresectable or metastatic) melanoma. The treatment is indicated for usage in adult and adolescent patients aged 12 years and above with tumour cell PD-L1 expression less than 1%.
MedCity News
SEPTEMBER 19, 2022
Bluebird Bio gene therapy Skysona has won FDA approval, making it the first FDA-approved therapy for cerebral adrenoleukodystrophy, an ultra-rare and fatal neurological disorder. Skysona’s regulatory green light follows the August approval of Zynteglo, a Bluebird gene therapy for a rare blood disorder.
Advertiser: ZoomInfo
One of the biggest challenges for any B2B marketer is understanding your prospects’ next move — who is most likely to buy and when. Without these insights, marketing campaigns can feel more like guesswork, with high investment and little return. We’re here to tell you there’s a better way. By tracking buyers’ digital footprints and online activity, such as website visits, product reviews, and spikes in content consumption, you can engage prospects with a message that really resonates.
Pharma Pathway
SEPTEMBER 19, 2022
Selmar Lab Pvt. Ltd-Walk-In Interview for Quality Assurance Dept. On 20th & 21st Sept’ 2022. Job Description. Selmar Lab Pvt. Ltd is located at Sy. No. 180/1 to 180/15 and 10/1, IDA, Kazipally, Jinnaram Mandal, Sangareddy District, Telangana. Selmar Lab Pvt. Ltd, We are Conducting Walk-In Interviews for Following.!!! Walk-In Interview for Quality Assurance Dept.
Medical Sales Authority
SEPTEMBER 19, 2022
Job hopping is becoming more popular these days. This is not a good thing in sales. Moving around roles every few years has become common for millennials. This may work in the technology sector where engineers are able to jump in and immediately contribute in a role. This does not pan out in sales. There are so much administrative tasks just to get started in an outside sales job.
Toolyt
SEPTEMBER 19, 2022
According to the study conducted by Gartner in 2022, only 14% of organizations have achieved a customer 360* view. When everyone is pushing hard to get more data on customers, often it paves way for incorrect, bad, and risky data, ultimately leading to negative customer support. In the current market trends, understanding what customers want from you paves the way to long-term success.
Copyright Clearance Center
SEPTEMBER 19, 2022
The post Peer Review Week 2022: A Matter of Trust? appeared first on Copyright Clearance Center.
Advertiser: ZoomInfo
In this eBook, we’ll run through real-world examples that show how RevOps teams can benefit from modern solutions for the access, management, and activation of their GTM data. Whether you need to improve lead response times, boost adoption of core tools, improve lead qualification, or target and automate your GTM motions, you’ll find examples of how revenue teams are solving some of the toughest problems in modern business.
Pharmacy Times
SEPTEMBER 19, 2022
Although there is no “best” way to determine which route of administration is best, health care providers are optimally positioned to educate patients and help them make the best decision.
Copyright Clearance Center
SEPTEMBER 19, 2022
The post 2022 “Global 50” Rankings for Publishers appeared first on Copyright Clearance Center.
Pharmacy Times
SEPTEMBER 19, 2022
The most important thing you must do is listen to the patient, understand their concerns, and by doing that, you will gain their trust to be able to treat them appropriately.
PharmaTech
SEPTEMBER 19, 2022
Discovery the industry's best kept secret.a fast-growing, end-to-end CDMO service provider in Nashville, TN that offers development, testing, and fill/finish cGMP manufacturing for sterile injectable and topical products – all under one roof. Whether your drug product is liquid or lyo, aseptically filled or requires terminal sterilization, the August Bio team brings to bear more than two decades of drug development and launch expertise.
Advertiser: ZoomInfo
Consolidating your tech stack is an effective cost-saving measure that drives GTM efficiency and adds value to your enterprise. With a cohesive, integrated tech stack, your revenue teams can deliver an excellent customer experience that sets you up to win faster than your competitors.
Expert insights. Personalized for you.
124 
Let's personalize your content